Greater Glasgow and Clyde Medicines

  Oral Proton Pump Inhibitors

• Proton Pump Inhibitors (PPIs) are one of the most commonly prescribed classes of drug
• PPIs are an effective treatment when used appropriately
• PPIs should only be prescribed where there is a clear indication
• PPIs are usually well tolerated
• Recent evidence suggests that PPIs may have potentially serious adverse effects such as fractures, hypomagnesaemia, subacute cutaneous lupus erythematosus, pneumonia and Clostridium difficile infection

Greater Glasgow and Clyde Area Drug and Therapeutics Committee met on Monday 14th December. This blog details the Formulary decisions made at that meeting.

New and updated NHSGGC Guidelines now available on StaffNet

Opioid drug users are at a high risk of a drug related death on discharge from hospital. Services have been developed to ensure those with a current or previous history of opiate misuse are given overdose awareness training and a naloxone suppl...

  Management of Urinary Incontinence and Overactive Bladder

• Lifestyle interventions and non-pharmacological strategies should be tried as first-line treatment.
• If pharmacological therapy is indicated, antimuscarinics should be tried first line.
• Immediate release (IR) oxybutynin, IR and modified release (MR) tolterodine and solifenacin are on the Preferred List of the Formulary.
• IR oxybutynin and IR tolterodine are significantly less expensive than other preparations on the Formulary, however, they may have less tolerability.
• MR tolterodine has similar efficacy and tolerability to solifenacin but is significantly less expensive, therefore, consider prescribing MR tolterodine prior to solifenacin.
• Patients should be reviewed 4 weeks after starting each new therapy and after a dose change.
• Patients on long term therapy should be reviewed annually or every 6 months if over 75 years.

Greater Glasgow and Clyde Area Drug and Therapeutics Committee met on Monday 19th October. This blog details the Formulary decisions made at that meeting.

GGC Guidelines now available on StaffNet

Information below is specific to the use of medicines in the adult setting. IV-Oral Antibiotic Switch Therapy (IVOST)The combin...

This is a blog created as a test displaying some of the Formulary decisions from Formulary Update (June 2015). It should not be used as a reference, and the original version should be referred to.

ADTC met on Monday 17th August. This blog entry contains all the Formulary decisions from that meeting.